Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

JACK L SCHWADE

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1245317742
CMS profile
237533
Location
DALLAS, TX

General Payments · PY2019–2025

$8,072.28

  • Reported across 410 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$426.16

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $426.16 16

By paying entity

PY2025 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,731.52 103
PY2020 $583.71 40
PY2021 $1,166.36 67
PY2022 $1,755.99 77
PY2023 $1,455.55 71
PY2024 $952.99 36
PY2025 $426.16 16

Payment records · PY2025 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2025 201920202021202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Actelion Pharmaceuticals US, Inc. $33.23 01/21/2025 Food and Beverage Undisputed 06/30/2026 1174296900 CMS
Actelion Pharmaceuticals US, Inc. $37.45 03/11/2025 Food and Beverage Undisputed 06/30/2026 1174296989 CMS
Actelion Pharmaceuticals US, Inc. $37.77 05/13/2025 Food and Beverage Undisputed 06/30/2026 1174297163 CMS
Alnylam Pharmaceuticals Inc. $23.56 04/08/2025 Food and Beverage Undisputed 06/30/2026 1212752901 CMS
Amgen Inc. $18.61 10/07/2025 Food and Beverage Undisputed 06/30/2026 1228641189 CMS
Bayer Healthcare Pharmaceuticals Inc. $30.20 02/21/2025 Food and Beverage Undisputed 06/30/2026 1225778097 CMS
Bayer Healthcare Pharmaceuticals Inc. $22.29 06/19/2025 Food and Beverage Undisputed 06/30/2026 1225778103 CMS
E.R. Squibb & Sons, L.L.C. $24.90 07/24/2025 Food and Beverage Undisputed 06/30/2026 1184882219 CMS
Kestra Medical Technology Services, Inc. $42.03 04/09/2025 Food and Beverage Undisputed 06/30/2026 1248827261 CMS
Merck Sharp & Dohme LLC $29.72 06/30/2025 Food and Beverage Undisputed 06/30/2026 1238341345 CMS
Novartis Pharmaceuticals Corporation $19.16 01/30/2025 Food and Beverage Undisputed 06/30/2026 1200474243 CMS
Novartis Pharmaceuticals Corporation $24.21 09/03/2025 Food and Beverage Undisputed 06/30/2026 1200474263 CMS
Novo Nordisk Inc $30.22 08/05/2025 Food and Beverage Undisputed 06/30/2026 1188699585 CMS
Novo Nordisk Inc $17.67 11/10/2025 Food and Beverage Undisputed 06/30/2026 1188261876 CMS
PFIZER INC. $21.38 03/19/2025 Food and Beverage Undisputed 06/30/2026 1231451887 CMS
Recor Medical Inc $13.76 07/29/2025 Food and Beverage Undisputed 06/30/2026 1245915352 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.